the respiratory secretions for bacterial culture across studies (sputum, protracted specimen brush). In addition, there is geographical variation in bacteriological profile in AE-COPD. Some studies have correlated lung function impairment and bacterial pathogen responsible for the exacerbation [12, 13] . Enterobacteriaceae and Pseudomonas are the predominantly isolated pathogens in those with significant impairment of pulmonary function (forced expiratory volume in 1 second [FEV 1 ] <50% of predicted]. Further, hospitalized patients usually have more severely compromised lung function, and the spectrum of the causative organisms could be different.
One of the major hurdle in defining the role of bacterial pathogen as causative agent of AE-COPD is the colonization of the airways by bacteria even in absence of an exacerbation. Despite the ongoing debate regarding this issue, there is ample evidence that implicates bacterial infections in AE-COPD indicated by high bacterial load [8] .
In this context, it would be helpful to determine patient characteristics that are associated with specific bacterial infection to guide empirical antibiotic therapy. Thus, we aimed to prospectively investigate the etiological agent (bacteria) implicated in AE-COPD of hospitalized patients, their relation to lung function, factors associated with isolation of particular pathogen and antibiotic sensitivity pattern.
MATERIAL AND METHODS

Study Participants
All hospitalized patients diagnosed with AE-COPD admitted to Pulmonary Medicine department of a tertiary care hospital in western India from January 2012 to December 2012, were prospectively evaluated. COPD was diagnosed according to the Global Initiative for Obstructive Lung Disease (GOLD) guidelines. AE-COPD was assumed when a patient presented with at least two of the three following symptoms, proposed by Anthonisen et al. [14] : (a) worsening dyspnea, (b) increased sputum volume, and (c) increased sputum purulence. Written informed consent was obtained from all the study participants. This study was approved by the institutional ethics committee.
The need for hospitalization was assessed according to the patient's clinical condition or the presence of other complicating factors, such as advanced age and lack of social support. Patients were excluded for the study if (1) they had an outpatient status; (2) received antibiotic within last 48 hours of hospital admission; (3) infiltrates were seen on chest radiograph; (4) other known chronic respiratory disorder; (5) active malignancy; (6) immunosuppression; and (7) long-term steroid use (>5 mg prednisolone or equivalent per day for more than 3 months). Patients were included only once in study even if they hospitalized frequently during study period.
Information about demographic characteristics, body mass index (BMI), dyspnea measured by the modified Medical Research Council (mMRC) was recorded. Data on smoking history in terms of pack years, number of acute exacerbations of COPD within the last year requiring hospitalization, use of systemic or inhaled corticosteroids and long-term oxygen therapy prior to admission were also collected. Arterial blood gases sample was obtained by puncture of the radial artery while patient was breathing on room air.
Bacteriological Data
At the time of hospital admission, spontaneously expectorated sputum samples were collected into a sterile container before institution of antibiotics. Gram's stain of the sputum samples were performed and only the samples consisting <10 epithelial cells and >25 leukocytes per low power field were processed for culture [15] . The sputum sample was homogenized with sputolysin and culture inoculum was prepared using 1 μL standard loop onto blood agar, chocolate agar, and MacConkey agar which were incubated in 5% CO 2 at 35°C for 18-24 hours. The culture plates were incubated further for additional 24 hours if no growth was observed after overnight incubation.
Bacterial agents were classified as potentially pathogenic microorganisms (PPMs) or non-PPMs. PPMs were only considered as significant if they achieved >10 6 /colony forming units (CFU), except in case of Streptococcus pneumoniae for which 10 5 /CFU was deemed sufficient [16] . A PPM had to grow in significant concentration to be considered as a causative agent of an exacerbation. The sensitivity pattern of the PPMs were carried out by minimum inhibitory concentration method and classified as sensitive, intermediate, or resistant according to Clinical Laboratory Standard Institute criteria [17] .
Lung Function
Spirometry was performed at follow-up after 6 weeks of discharge from hospital as per the GOLD guidelines [18] . Post bronchodilator reversibility of FEV 1 was assessed by repeating spirometry 20 min after inhalation of salbutamol (400 μg) given through a volume spacer. Based on the GOLD staging of severity, lung functions were categorized into four stages: stage 1, FEV 1 ≥80% predicted; stage 2, FEV 1 50%-80% predicted; stage 3, FEV 1 30%-50% predicted; and stage 4: FEV 1 <30% predicted.
Patients were treated with a standard management protocol consisting of systemic corticosteroids, nebulized short-acting bronchodilators (salbutamol, ipratropium bromide), and O 2 was titrated according to continuous monitoring of peripheral oxygen saturation. Antibiotics were prescribed after the availability of the sputum culture results unless patient's clinical condition necessitated an early intervention. Patients were advised to attend outpatient clinic regularly for follow-up and adhere to the treatment. All the current smokers were advised to quit smoking. Patients with GOLD stage 2 or more were provided influenza and pneumococcal vaccination as per GOLD guidelines recommendations.
Statistical Analysis
Statistical analyses were performed using the Statistical Package for Social Sciences software for windows version 21.0 (IBM Corp.; Armonk, NY, USA). The quantitative variables were expressed as mean and standard deviation and qualitative variables were expressed as counts and percentage. For indepenTurk Thorac J 2018; 19: 19-27 dent samples, comparison between means was performed using student's t-test. Mann-Whitney U test was used for the variables that did not meet the normal distribution criteria. The chi-square test was used to compare categorical variables. One-way Analysis of Variance (ANOVA) was used for between-group analyses.
A logistic regression model was constructed for individual PPMs isolated in sputum. The independent variables were following: age (0=<55 years; 1=>55 years), BMI (0=<18.5; 1=>18.5), smoking (0=ex and non-smoker; 1=current smoker), FEV 1 (0=<50%; 1=>50%), exacerbation history in previous year (0=≤1 exacerbation; 1=≥2 exacerbation), systemic steroid use (0=no; 1=yes). Variables with p value <0.05 were selected for the model and analyzed. A p value of <0.05 was considered to be significant.
RESULTS
During the study period, 90 patients were recruited based on the inclusion and exclusion criteria. Among them, four patients died (two as inpatient and two after discharge) and three patients defaulted during follow-up. Out of remaining 83 patients, 6 patient's sputum sample did not meet the adequacy criteria and five patients were not fulfilling the criteria for acceptability of spirometry (2 not able to perform, three had FEV 1 /forced vital capacity [FVC] >0.7) and hence were excluded. Thus, we included a total 72 cases of AE-COPD in the final analysis.
The demographic details and baseline characteristics of study participants are summarized in Table 1 . The majority of the patients were males (91.66%) with mean ± standard deviation (SD) age of 59±9.6 years and were current smokers (43.05%). Majority of the patients had moderate to severe stage of COPD with mean post bronchodilator FEV 1 of 1.23±0.48 liters and 54±18% of predicted.
In our study, quantitative analysis of sputum culture revealed growth of PPMs in 34 (47.22%) hospitalized patients with AE-COPD (Figure 1 ). Of these 34 isolates, Pseudomonas aeruginosa (n=13, 38.23%) was the most predominant organism followed by Klebsiella pneumoniae (n=10, 29.41%), Staphylococcus aureus (n=8, 23.53%), Streptococcus pneumoniae (n=2, 5.88%), and Acinetobacter spp. (n=1, 2.94%). Therefore, GNBs clearly outnumbered other organisms.
We compared the characteristics of the patients who revealed growth of PPMs versus non-PPMs (Table 2 ). There were statistically significant differences with regard to age (p=0.02), number of exacerbations in previous year (p<0.001), lung function (FEV 1 , p=0.02; FEV 1 /FVC, p=0.016) and systemic corticosteroids use (p=0.005). No significant difference was noted in BMI, smoking pack years, inhaled steroids use, home oxygen use, and arterial blood gas measures.
Isolation of P. aeruginosa was significantly more common in patients with frequent exacerbations requiring hospitalization (p=0.005) and systemic steroid use (p=0.041) as compared to other pathogens (Appendix 1). Figure 2 ). There was severe impairment in lung functions (FEV 1 ) with isolation of P. aeruginosa and K. pneumoniae compared to non-PPMs that was statistically significant (p=0.030 and p=0.038, respectively).
We stratified the patients showing growth of PPMs according to GOLD stages of COPD for estimation of betweengroup differences among various variables using ANOVA ( Binary logistic regression analysis was used to determine factors independently associated with the isolation of PPMs ( The analysis of the sensitivity pattern of different antibiotics to the PPMs revealed that majority of the isolates were showing resistance to aminopenicillins, macrolides, and tetracycline, the commonly used antibiotics in these patients (Table 6 ). Ciprofloxacin and piperacillin/tazobactum were effective in 79.41% of isolates followed by gentamycin in 76%. They appear to be most appropriate drugs for majority of the microorganisms isolated from hospitalized AE-COPD patients.
DISCUSSION
In the present study, bacterial pathogens (PPMs) were identified in 47% of all hospitalized patients, based on sputum culture. P. aeruginosa and K. pneumoniae were the most frequently isolated organisms. Boixeda et al. [19] reported Pseudomonas in 38.23% of cases and Eller et al. [13] reported Pseudomona sand Enterobacteriaceae spp. in 48.2% patients of their study. Thus, this is in line with the previous studies. However, we did not detect H. influenza and M. catarrhalis as pathogenic organisms in our study, although they have been reported to be a common pathogen in the literature based on the western population. This could be explained by the fact that our patients had severe exacerbation of COPD necessitating hospitalization, and we had excluded outpatients, wherein these pathogens are reported to be more prevalent. This difference could also be explained by different environment condition and inadvertent use of antibiotics in this region.
Lung function impairment has been consistently found to be a strong predictor for bacterial infection (particularly GNBs) in AE-COPD. In our study, we observed that deterioration of the lung function was significantly associated with isolation of the pathogenic organisms [FEV 1 % predicted (mean) 49.03 vs 58.55; p=0.022] in which P. aeruginosa and K. pneumoniae were present in 67.64% of isolates. Studies on relationship between bacterial flora and pulmonary function have consistently revealed higher prevalence of GNBs among those with significant functional impairment (FEV 1 , < 50% of predicted).
In a retrospective study of hospitalized patients of AE-COPD, a bacterial pathogen was reported in 53% of patients [13] . Among them, Pseudomonas and other GNBs were isolated in nearly one-half of the cases. In the patients with FEV 1 <50% of predicted, majority of the episodes (83.33%) were caused by these organisms. Similar observation was also made by Miravitlles et al. [12] who reported high incidence of Pseudomonas among the patients with FEV 1 <50% of predicted. Thus, the present study also supports the finding of previous studies that reported higher incidence of GNBs in patients with severely compromised lung function.
In the present study, another risk factor for isolation of PPMs was number of exacerbations in the previous year requiring hospitalization (p<0.001). Frequent exacerbations (>2 episodes per year) are due to the different phenotype of COPD that have susceptibility to recurrent exacerbations irrespective of severity of COPD [20] . They have been associated with severe symptoms, greater reduction in exercise capacity and a greater decline in health status as compared to patients with fewer exacerbations [20] . Recurrent exacerbations are assumed to be associated with faster decline in lung function. This decline in lung function favors colonization and/ or infection with bacterial pathogen by breach in host defense, such as epithelial cell damage, mucous hypersecretion, decreased ciliary beat frequency, and inflammatory cell infiltrates which makes them susceptible for exacerbation [21] . This vicious cycle further leads to more frequent exacerbation and rapid decline in lung function.
Isolation of Pseudomonas in patients with AE-COPD has been reported to be associated with certain risk factors, including FEV 1 <35%, systemic steroid use, and prior antibiotic therapy within the preceding months [22] [23] [24] . Another study stated further risk factors for Pseudomonas isolation, such as functional dependence, dyspnea score, walking distance, oral corticosteroid treatment, and the Body mass index, airflow Obstruction, Dyspnea, and Exercise (BODE) index [25] . In our study, isolation of Pseudomonas was significantly higher in patients with frequent exacerbations in the previous year requiring hospitalization and systemic steroid use. Although lung function was impaired in this patient population, the statistical significance was not observed (p=0.079).
The major risk factor independently associated with isolation of P. aeruginosa and K. pneumoniae (binary regression analysis) was hypercapnic respiratory failure (PaCO 2 > 45 mmHg). A similar observation was made by Soler et al. [26] that presence of GNBs and Pseudomonas must be considered in all patients presenting with acute exacerbations and respiratory Turk Thorac J 2018; 19: 19-27 failure requiring mechanical ventilation. However, they did not include arterial blood gas values in their analysis.
The higher proportion (29.41%) of isolation of K. pneumoniae in the present study also deserves special mention. Lin et al. [27] reported high prevalence of infection with K. pneumoniae (19.6%) and P. aeruginosa (16.8%) among hospitalized patients of AE-COPD. However, the isolation of Klebsiella was predominated in mild COPD. Ye et al. [28] observed that K. pneumoniae was responsible for acute exacerbation of COPD in 12.3% of patients. The present study demonstrated rather higher prevalence of isolation of K. pneumoniae (29.41% of cases). The possible reason for the frequent isolation of K. pneumoniae could be advanced underlying disease and frequent use of systemic steroids among this patient population. Multiple logistic regression analysis revealed that isolation of K. pneumoniae was independently associated with advanced age and systemic steroids use.
We did not perform high resolution computed tomography scan among our cases so the possibility of subtle bronchiectasis could not be ruled out, which is a common risk factor for GNBs including Klebsiella.
Another major risk factor that may contribute to higher number of GNBs in our study is systemic corticosteroid use. In our study, 10 out of 72 patients (13.89%) were on chronic steroid use, of which 90% revealed a pathogen in sputum culture. Eller et al. [13] observed that GNB isolation was more frequent among patients taking oral steroids (54.2%) as compared to those not taking them (33.3%). Long-term treatment with corticosteroids weakens adaptive immune response by down-modulating MHC class II and costimulatory molecules [29] . Systemic steroid use was also reported to be associated with poor clearance of causative microbes of acute exacerbation following antibiotic treatment [30] .
Our study showed that majority of PPMs remain susceptible to ciprofloxacin and piperacillin/tazobactum. This is in line with the recent guidelines that suggest that these drugs to be considered as empirical treatment in patients with deranged lung functions [31] . The present study was not designed to evaluate whether their use can improve the prognosis in these patients. Further studies are needed to clarify the role of particular antibiotic among these cases.
There are several limitations in our study that need to be addressed. First, we have used sputum sample for culture that can be a source of contamination with nasopharyngeal organisms. To overcome this issue, we have used sputum validity criteria proposed by various authors [15, 32] . Furthermore, quantitative analysis of sputum culture showed good concordance with the bronchoscopic PSB results [26] . This finding supports the use of sputum with quantitative analysis as an easy method to procure a non-invasive form of sample and was used in various studies [12, 13, 27] .
Second, our study did not include serodiagnosis and viral culture and/or polymerase chain reaction, which could have helped in finding the etiological agents in few more patients. Some studies have shown that significant proportion of acute exacerbations in COPD may be due to atypical pathogens like Chlamydia pneumoniae, Mycoplasma pneumoniae, and respiratory viruses [26, 33, 34] . However, these studies have been performed either in outpatients or in mechanically ventilated patients who are not representative of hospitalized AE-COPD population included in the present study.
In conclusion, Pseudomonas and Klebsiella were the most common bacterial pathogen recovered from hospitalized AE-COPD patients. These pathogens were seen particularly in those patients with more severely compromised lung function. Hypercapnic respiratory failure is an independent risk factor for isolation of these organisms in addition to advanced age and systemic steroid use. Most isolates were resistant to the first-line antibiotics used in AE-COPD. These factors may be an important adjunct in deciding the initial antibiotic therapy. Further studies are needed for better understanding of etiology of AE-COPD and their association with respiratory failure as there is limited evidence regarding its.
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